ChemoCentryx, Inc. (CCXI) Announces Financial Results for the Quarter Ended September 30, 2013
11/8/2013 9:35:04 AM
MOUNTAIN VIEW, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today its financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by